POWERFUL NEWS:

MMRF PRESS RELEASES


Baylor and Stottlemyre Join to Raise Awareness of Rare Blood Cancer


New York — July 6, 2004

Coaches from the New York Mets and New York Yankees living with multiple myeloma, champion the Multiple Myeloma Research Foundation's First Annual Score for a Cure Program

During the Subway Series, one of the fiercest rivalries in sports, Don Baylor, hitting coach for the Mets and Mel Stottlemyre, pitching coach for the Yankees, joined Kathy Giusti, president of the Multiple Myeloma Research Foundation (MMRF), to throw out the first pitch to kick-off the first annual MMRF 'Score for a Cure' program.

"We wish to thank Don Baylor and Mel Stottlemyre for their dedication to raise awareness of multiple myeloma - a disease touching the hearts of New York baseball," said Kathy Giusti, president and co-founder of the MMRF. "Just 8 years ago there were not many resources available for a multiple myeloma patient. With the support of families like the Baylors and Stottlemyres, the MMRF continues to march forward in search of a cure for the more than 50,000 people living this rare disease."

MMRF 'Score for a Cure' raised nearly $75,000 dollars for multiple myeloma research. Since the Foundation was founded, the MMRF has raised more than 50 million dollars with 93% used toward research and programming. The money raised during the MMRF 'Score for a Cure' program will support the Foundation's mission of accelerating a cure for multiple myeloma.

Championed by Baylor and Stottlemyre, MMRF 'Score for a Cure' is a program in which corporate sponsors UBS, Millennium Pharmaceuticals and Novartis were invited to donate funds for multiple myeloma research during the 4th of July Subway Series. Fans could also participate in MMRF ‘Score for a Cure’ by making donations online on behalf of the players.

About Multiple Myeloma

Multiple myeloma, a cancer of the plasma cell, is an incurable but treatable disease. While a myeloma diagnosis can be overwhelming, it is important to remember that there are several promising, new therapies that are helping patients live longer, healthier lives. There are approximately 50,000 people in the United States living with multiple myeloma. Each year, an estimated 15,270 new cases of multiple myeloma are diagnosed and another 11,070 people die from the disease. Multiple myeloma is the second most prevalent blood cancer after non-Hodgkin's lymphoma. It represents approximately 1% of all cancers and 2% of all cancer deaths.

About the MMRF

The MMRF was established in 1998 and founded by twin sisters Karen Andrews and Kathy Giusti, after Kathy was diagnosed with multiple myeloma. Today, the MMRF is the largest nonprofit foundation dedicated to the single mission of accelerating the search for a cure for multiple myeloma.

As the world's number-one private funder of myeloma-specific research, the MMRF has raised more than $50 million, funding more than 49 research institutions around the globe and supporting the most promising areas of multiple myeloma research. This year alone, the MMRF will fund $5 million in research grants.

Through the building of interdisciplinary collaborations among researchers, pharmaceutical companies, biotech firms, and the National Cancer Institute, the MMRF is expanding therapeutic treatments for myeloma and extending the lives of multiple myeloma patients worldwide.

For information, contact:
Anne Quinn Young, MMRF, 203-652-0212, quinnyoung@www.themmrf.org